Scientists test groundbreaking HIV vaccine in first human volunteers
NCT ID NCT06905275
Summary
This is the first human study of two experimental HIV vaccines given in combination. Researchers want to see if the vaccines are safe and if they trigger a strong immune response in healthy volunteers without HIV. The study will enroll 25 participants who will be monitored for about one year through blood tests and clinic visits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alabama CRS (#31788)
Birmingham, Alabama, 35222, United States
-
Columbia P&S CRS (#30329)
New York, New York, 10032, United States
-
University of Rochester Medical Center
Rochester, New York, 14642, United States
-
Vanderbilt Vaccine (VV) CRS (#30352)
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.